Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy
NCT ID: NCT05018325
Last Updated: 2022-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
32 participants
INTERVENTIONAL
2021-08-30
2022-08-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times
NCT01802008
9 Minutes for Colonoscopy Withdrawal
NCT03399045
The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.
NCT02538406
9 Minutes for Tandem Colonoscopy Withdrawal
NCT04797065
The Utility of Timed Segmental Withdrawal During Screening Colonoscopy
NCT02132455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: Colonoscopy 6 minute withdrawal time
-Undergo colonoscopy with the standard 6-minute withdrawal time followed by a tandem colonoscopy of at least another 6-minute withdrawal time.
Colonoscopy with 6 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Arm 2: Colonoscopy 9 minute withdrawal time
-Undergo a 9-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time.
Colonoscopy 9 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Arm 3: Colonoscopy 12 minute withdrawal time
-Undergo colonoscopy with a 12-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time
Colonoscopy 12 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy with 6 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Colonoscopy 9 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Colonoscopy 12 minute withdrawal
Withdrawal time will be determined using a digital stopwatch by the nursing staff.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be a patient undergoing screening or surveillance colonoscopy
* Must be able to understand and willing to sign an IRB-approved written informed consent document.
Exclusion Criteria
* Personal history of colorectal cancer (CRC)
* Personal history of colon surgery or colon resection
* Personal history of Inflammatory bowel disease
* Personal history of familial polyposis
* Current pregnancy
* Active GI bleeding
* Colonoscopy exams where the cecum cannot be reached (randomization will occur after cecum is reached).
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Kushnir, M.D.
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202103025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.